Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDC2-like kinase 4 is an important regulator in mRNA processing through its control over alternative splicing via phosphorylation events on SR proteins. Its dysregulation contributes to several pathologies including cancers and neurodegenerative diseases. As such it represents an attractive target for drug discovery efforts focused on modulating RNA processing pathways in disease contexts.
Inhibition of CLK4 leads to altered phosphorylation patterns on SR proteins, affecting splice variant production.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDC2-like kinase 4 (None).